Edwards Lifesciences Corporation
EW | NYSE
$94.84
+$2.83 (+3.08%)
Nov 2, 2026, 12:10 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 6.51B | 6.3B | 6.07B | 5.88B | 5.69B | 5.54B | 5.46B | 5.34B | 5.23B | 5.14B | 5.26B | 5.35B | 5.42B | 5.5B | 5.38B | 5.36B | 5.36B | 5.36B | 5.23B | 5.09B | 4.93B | 4.47B |
Cost of Revenue | 1.44B | 1.39B | 1.33B | 1.28B | 1.2B | 1.15B | 1.14B | 1.1B | 1.11B | 1.08B | 1.15B | 1.2B | 1.21B | 1.22B | 1.17B | 1.18B | 1.2B | 1.24B | 1.23B | 1.21B | 1.2B | 1.12B |
Gross Profit | 5.08B | 4.92B | 4.74B | 4.6B | 4.49B | 4.38B | 4.31B | 4.24B | 4.12B | 4.05B | 4.11B | 4.15B | 4.22B | 4.28B | 4.21B | 4.18B | 4.15B | 4.11B | 4.01B | 3.88B | 3.73B | 3.36B |
Operating Income | 1.83B | 1.74B | 1.62B | 1.56B | 1.49B | 1.42B | 1.38B | 1.43B | 1.42B | 1.43B | 1.48B | 1.53B | 1.61B | 1.67B | 1.7B | 1.65B | 1.63B | 1.66B | 1.61B | 1.61B | 1.55B | 1.33B |
Interest Income | 138M | 145.4M | 131.4M | 139.7M | 124.6M | 103.7M | 103.2M | 75.8M | 68.6M | 65M | 52.9M | 42.4M | 31.2M | 18.3M | 11.4M | 5.1M | n/a | n/a | n/a | n/a | n/a | 200K |
Pretax Income | 1.42B | 1.3B | 1.27B | 1.57B | 1.63B | 1.61B | 1.55B | 1.53B | 1.51B | 1.4B | 1.43B | 1.52B | 1.54B | 1.73B | 1.77B | 1.68B | 1.67B | 1.75B | 1.7B | 1.68B | 1.66B | 941.5M |
Net Income | 1B | 1.09B | 1.07B | 1.36B | 4.14B | 4.18B | 4.17B | 4.16B | 1.47B | 1.41B | 1.4B | 1.43B | 1.39B | 1.49B | 1.52B | 1.46B | 1.46B | 1.54B | 1.5B | 1.48B | 1.46B | 851M |
Selling & General & Admin | 2.2B | 2.14B | 2.09B | 1.97B | 1.88B | 1.83B | 1.79B | 1.72B | 1.68B | 1.64B | 1.65B | 1.64B | 1.64B | 1.63B | 1.57B | 1.58B | 1.57B | 1.53B | 1.49B | 1.41B | 1.35B | 1.25B |
Research & Development | 1.09B | 1.09B | 1.08B | 1.08B | 1.06B | 1.05B | 1.05B | 1.02B | 1.01B | 985.3M | 989.8M | 979.9M | 970.7M | 977.8M | 945.2M | 945.8M | 950.2M | 924.7M | 903.1M | 866M | 823.5M | 780.3M |
Other Expenses | -42.8M | -53.1M | -46.2M | -16.3M | 60.6M | 80.1M | 84.1M | 66.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 3.25B | 3.18B | 3.12B | 3.04B | 3B | 2.96B | 2.93B | 2.81B | 2.69B | 2.62B | 2.64B | 2.62B | 2.61B | 2.61B | 2.51B | 2.53B | 2.52B | 2.46B | 2.4B | 2.27B | 2.17B | 2.03B |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.1M | 2.1M | 3.3M | 5.7M | 7.1M | 7.4M | 7.2M | 5.6M | 3.1M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.68B | 4.56B | 4.45B | 4.32B | 4.2B | 4.12B | 4.07B | 3.91B | 3.8B | 3.71B | 3.79B | 3.82B | 3.81B | 3.83B | 3.68B | 3.71B | 3.72B | 3.7B | 3.62B | 3.48B | 3.37B | 3.15B |
Income Tax Expense | 439M | 224.9M | 216.9M | 235.8M | 220.4M | 176.3M | 152.3M | 141.3M | 153.3M | 154M | 165.8M | 192.6M | 203.7M | 241.1M | 245.5M | 225.6M | 212.6M | 210.3M | 198.9M | 204.5M | 192.8M | 90.5M |
Shares Outstanding (Basic) | 576.4M | 579.2M | 580.4M | 584.7M | 587M | 586.9M | 589.8M | 597.2M | 602.1M | 601.6M | 605.2M | 607M | 606.9M | 607.5M | 612.9M | 619.8M | 620.9M | 622.1M | 624.1M | 623.6M | 622.3M | 623.2M |
Shares Outstanding (Diluted) | 577.6M | 580.7M | 581.8M | 585.7M | 587.9M | 587.8M | 590.5M | 598.1M | 604.3M | 604.1M | 606.9M | 609.5M | 610.3M | 610.9M | 616.2M | 624.5M | 626.7M | 629.4M | 632M | 631.7M | 629.9M | 631.3M |
EPS (Basic) | 1.74 | 1.89 | 1.84 | 2.33 | 6.97 | 7.01 | 6.98 | 6.94 | 2.43 | 2.33 | 2.31 | 2.35 | 2.27 | 2.41 | 2.45 | 2.34 | 2.34 | 2.48 | 2.42 | 2.38 | 2.35 | 1.36 |
EPS (Diluted) | 1.74 | 1.88 | 1.83 | 2.32 | 6.95 | 7 | 6.97 | 6.93 | 2.43 | 2.32 | 2.30 | 2.34 | 2.26 | 2.41 | 2.44 | 2.32 | 2.31 | 2.44 | 2.39 | 2.35 | 2.33 | 1.35 |
EBITDA | 1.54B | 1.42B | 1.39B | 1.74B | 1.78B | 1.81B | 1.75B | 1.67B | 1.66B | 1.55B | 1.58B | 1.68B | 1.7B | 1.9B | 1.94B | 1.85B | 1.84B | 1.92B | 1.87B | 1.85B | 1.82B | 1.09B |
EBIT | 1.42B | 1.26B | 1.23B | 1.59B | 1.63B | 1.66B | 1.59B | 1.52B | 1.51B | 1.4B | 1.43B | 1.52B | 1.54B | 1.73B | 1.77B | 1.69B | 1.67B | 1.76B | 1.71B | 1.69B | 1.66B | 944.6M |
Depreciation & Amortization | 122.8M | 160.9M | 156.6M | 156.5M | 151.8M | 153.3M | 155.2M | 149.3M | 151.7M | 148.2M | 151.7M | 157M | 162.2M | 167M | 166.8M | 164.9M | 163.5M | 165.4M | 163.3M | 163.3M | 155.6M | 143.9M |
Add to Watchlist
Select watchlists to add or remove EW